Archive for September 26th, 2009

Surgery Best for Carpal Tunnel Syndrome (HealthDay)

Saturday, September 26th, 2009

HealthDay – THURSDAY, Sept. 24 (HealthDay News) — Surgery is slightly better than
non-surgical treatment for patients with carpal tunnel syndrome who don’t
have severe nerve damage (denervation), new research has found.

Antidepressants Linked to Heart Defects in Newborns (HealthDay)

Saturday, September 26th, 2009

HealthDay – THURSDAY, Sept. 24 (HealthDay News) — Women who take certain
antidepressants during the first three months of pregnancy may have a
slightly increased risk of giving birth to babies with heart defects.

FDA Acknowledges Mistakes in Knee-Device Approval (HealthDay)

Saturday, September 26th, 2009

HealthDay – THURSDAY, Sept. 24 (HealthDay News) — The U.S. Food and Drug
Administration violated procedures last year when it approved a knee
repair device even though its own scientists recommended against approval,
agency officials said Thursday.

Health Tip: Help Prevent Your Child’s Constipation (HealthDay)

Saturday, September 26th, 2009

HealthDay – (HealthDay News) — Constipation is a common problem in children
and can be painful for young ones. But you can take steps to help prevent
constipation in your child.

Health Tip: Understanding Gum Disease (HealthDay)

Saturday, September 26th, 2009

HealthDay – (HealthDayNews) — Your risk of developing gum (periodontal)
disease increases as you age. Over time, your gums may begin to detach
from your teeth.

New Hope for Treatment of Pancreatic Cancer (HealthDay)

Saturday, September 26th, 2009

HealthDay – FRIDAY, Sept. 25 (HealthDay News) — Inhibiting the action of an enzyme
called TAK-1 reverses pancreatic cancer resistance to chemotherapy, a
finding that could lead to the development of a new way to treat the
disease, researchers say.

Spanking May Lower Kids’ IQs (HealthDay)

Saturday, September 26th, 2009

HealthDay – FRIDAY, Sept. 25 (HealthDay News) — The bad news is that youngsters
who are spanked might lose IQ points.

Clinical Trials Update: Sept. 25, 2009 (HealthDay)

Saturday, September 26th, 2009

HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy
of ClinicalConnection.com:

Folotyn Approved for Aggressive Type of Non-Hodgkin’s Lymphoma (HealthDay)

Saturday, September 26th, 2009

HealthDay – FRIDAY, Sept. 25 (HealthDay News) — The drug Folotyn
(pralatrexate) has been approved to treat Peripheral T-cell Lymphoma
(PTCL), an often aggressive form of non-Hodgkin’s lymphoma, the U.S. Food
and Drug Administration said Friday.

Health Highlights: Sept. 25, 2009 (HealthDay)

Saturday, September 26th, 2009

HealthDay – Here are some of the latest health and medical news developments,
compiled by editors of HealthDay: